‘Don’t go with a fund, go with a solution’: CEO’s tips from decades of global investing

BlueFive Capital CEO Hazem Ben-Gacem said Middle Eastern sovereign capital is prioritizing investments that address national strategic needs, particularly food security, defense, infrastructure, automation and robotics. BlueFive, launched in November 2024 with $15 billion of AUM as of June 30, recently acquired a 30% stake in Bugatti Rimac from Porsche and co-led Kling AI's July funding round at an $18 billion valuation. Ben-Gacem cautioned that geopolitics has become a major determinant of investment returns across the Middle East, Europe and Asia, capable of undermining core investment assumptions.

Analysis

The relevant public-market implication is not a broad AI or defense beta signal; it is a shift in the marginal buyer toward assets with sovereign-policy relevance and controllable geopolitical exposure. European industrial franchises with dual-use technology, local production footprints, and exportable service revenue should command a valuation premium versus discretionary manufacturers whose China exposure is difficult to hedge. For PAH3, the strategic investment may be more valuable as balance-sheet optionality and a route to monetize non-core stakes than as a near-term earnings driver; the key question is whether proceeds are redirected toward debt reduction or protected dividends rather than further illiquid investments.

Over the next 1-3 months, sovereign capital deployment could support private-market marks in defense autonomy, robotics, grid equipment, water, and controlled-environment agriculture, but listed names already trading on defense scarcity are vulnerable to crowded positioning. The more durable 6-18 month effect is likely a widening cost-of-capital gap: companies qualifying as strategic partners can access patient capital and long-duration contracts, while globally exposed suppliers face higher localization capex and lower asset turns. The contrarian risk is that headline sovereign commitments do not translate into procurement revenue; budget approval, technology-transfer restrictions, and local-content requirements can leave minority investors with expensive, illiquid exposure.

PAH3 should not be bought solely on this transaction. A rerating requires evidence that portfolio monetization improves Porsche SE's net asset value discount, alongside stabilization in Volkswagen-related earnings and China demand; absent these, the stake is too small and too opaque to offset automotive-cycle risk.

Key Decisions for Investors

• Maintain PAH3 as a watch item rather than a directional long. Reassess after the next results release for net-debt movement, dividend coverage, and an explicit valuation/disclosure of strategic holdings; a narrowing of the NAV discount, not the private transaction itself, is the catalyst.
• For a 6-12 month strategic-capital theme, prefer a diversified long basket of RHM, SAAB-B, ABB, and Schneider Electric (SU) over venture-backed AI proxies. These names have clearer routes from sovereign priorities to backlog and service revenue; size defensively because defense multiples already embed elevated order expectations.
• Express the localization-capex divergence through long ABB or SU versus short a broad European discretionary-auto proxy such as EXV1, only after a relative-strength pullback. Thesis: grid/automation orders retain pricing power while auto suppliers absorb capex and China-related volume risk; invalidate if European PMI improves materially and auto production guidance is revised upward.
• Set an alert for evidence of large Middle East procurement awards or co-investment vehicles with disclosed public-company beneficiaries. Without named contracts, committed capex, or order-book conversion, treat private-market fundraising and minority-stake announcements as sentiment rather than earnings catalysts.